RISK FACTORS FOR DEVELOPING RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS AFTER IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS

被引：0
|
作者：
Liapi, M. [1 ]
Chatzidionysiou, K. [1 ]
机构：
[1] Karolinska Inst, Rheumatol Div, Dept Med Solna, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Malignancy;
D O I：
10.1136/annrheumdis-2023-eular.6181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1638
引用
收藏
页码：2053 / 2054
页数：2
相关论文
共 50 条
  • [31] ONE-YEAR OUTCOMES AFTER RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FROM CHECKPOINT INHIBITORS
    Berard, E.
    Barnetche, T.
    Rouxel, L.
    Dutriaux, C.
    Dousset, L.
    Prey, S.
    Beylot-Barry, M.
    Seneschal, J.
    Veillon, R.
    Vergnenegre, C.
    Daste, A.
    Domblides, C.
    Sionneau, B.
    Gross-Goupil, M.
    Ravaud, A.
    Forcade, E.
    Schaeverbeke, T.
    Kostine, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1223 - 1223
  • [32] Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancer
    Sebastiani, Gian Domenico
    Scirocco, Chiara
    Galeazzi, Mauro
    AUTOIMMUNITY REVIEWS, 2019, 18 (08) : 805 - 813
  • [33] Rheumatic immune-related adverse events from cancer immunotherapy
    Calabrese, Leonard H.
    Calabrese, Cassandra
    Cappelli, Laura C.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) : 569 - 579
  • [34] Rheumatic immune-related adverse events from cancer immunotherapy
    Leonard H. Calabrese
    Cassandra Calabrese
    Laura C. Cappelli
    Nature Reviews Rheumatology, 2018, 14 : 569 - 579
  • [35] Analysis and evaluation of factors contributing to the occurrence of immune-related adverse events with immune checkpoint inhibitors
    Nagase, T.
    Shima, O.
    Maruhana, N.
    Miyazawa, Y.
    Yoshino, S.
    Sato, J.
    Yamada, H.
    Shinozaki, K.
    Ikeda, K.
    PHARMAZIE, 2024, 79 (7-8): : 163 - 168
  • [36] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Yang, Kaili
    Li, Jiarui
    Sun, Zhao
    Bai, Chunmei
    Zhao, Lin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3907 - 3918
  • [37] Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
    Kaili Yang
    Jiarui Li
    Zhao Sun
    Chunmei Bai
    Lin Zhao
    Clinical and Experimental Medicine, 2023, 23 : 3907 - 3918
  • [38] Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancer
    Tang, X-R.
    Li, R.
    Zhao, F.
    Wen, X.
    Wang, Y-K.
    Lv, R-X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1269 - S1269
  • [39] Immune-related adverse events after ≥12 months of starting immune checkpoint inhibitors.
    Jovaisaite, Agne
    Serrano, Marina
    Jackson-Spence, Francesca
    Young, Matthew
    Toms, Charlotte
    Wang, Yishen
    Nally, Elizabeth
    Szabados, Bernadett
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults
    Schonfeld, Sara J.
    Tucker, Margaret A.
    Engels, Eric A.
    Dores, Graca M.
    Sampson, Joshua N.
    Shiels, Meredith S.
    Chanock, Stephen J.
    Morton, Lindsay M.
    JAMA NETWORK OPEN, 2022, 5 (03)
12345